RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer
I. Guerreiro(Administração Regional de Saúde de Lisboa e Vale do Tejo), Cármen Jerónimo(Universidade do Porto), Ana Rodrigues(Instituto Português de Oncologia Francisco Gentil), Luís Antunes(Instituto Português de Oncologia Francisco Gentil), Rui Henrique(Universidade do Porto), Mariana Cantante(Instituto Português de Oncologia Francisco Gentil), Daniela Barros‐Silva(Instituto Português de Oncologia Francisco Gentil), João Lobo(Universidade do Porto), Paula Lopes(Instituto Português de Oncologia Francisco Gentil), Ana Luísa Cunha(Instituto Português de Oncologia Francisco Gentil), Marta Soares(Instituto Português de Oncologia Francisco Gentil)
Cited by 9
Related Papers
Integrative epigenetic taxonomy of primary prostate cancer
|Nature Communications|2018|167
Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
|International Journal of Molecular Sciences|2019|141
Data Sharing Under the General Data Protection Regulation
|Hypertension|2021|136
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
|Nature Reviews Urology|2020|112
<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
|Histopathology|2022|112